BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22349904)

  • 1. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.
    Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F
    Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme.
    Gera L; Bawolak MT; Roy C; Lodge R; Marceau F
    J Pharmacol Exp Ther; 2011 Apr; 337(1):33-41. PubMed ID: 21205920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
    Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional epitope-agonist ligands of the bradykinin B(2) receptor.
    Gera L; Roy C; Marceau F
    Biol Chem; 2013 Mar; 394(3):379-83. PubMed ID: 23241671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: insight into the endosomal inactivation of kinins.
    Bawolak MT; Roy C; Gera L; Marceau F
    Pharmacol Res; 2012 Feb; 65(2):247-53. PubMed ID: 22108573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
    Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
    Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
    MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
    Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
    Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
    Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
    Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F
    Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.